Importance of posttreatment nadir M-protein level in the evaluation of the treatment for multiple myeloma.

被引：0
|
作者：
Shimizu, K [1 ]
Kamiya, O [1 ]
Takeyama, H [1 ]
Mizuno, H [1 ]
Kawashima, K [1 ]
机构：
[1] NAGOYA CITY HIGASHI GEN HOSP,CHIKUSA KU,NAGOYA,AICHI,JAPAN
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4112 / 4112
页数：1
相关论文
共 50 条
  • [1] Posttreatment M-protein nadir level is a significant prognostic factor associated with survival in multiple myeloma
    Shimizu, K
    Kamiya, O
    Hirabayashi, N
    Ichikawa, A
    Kawashima, K
    Kobayashi, M
    Mizuno, H
    Nagura, E
    Nitta, M
    Saito, H
    Sao, H
    Shibata, T
    Takeyama, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (03): : 355 - 360
  • [2] Posttreatment nadir M-protein level is a stronger discriminator of survival following plateau attainment than is percent reduction in M-protein in patients with IgG myeloma
    Shimizu, K
    Nagura, E
    Hirabayashi, N
    Wakita, A
    Takeyama, H
    Sao, H
    Nitta, M
    Kawashima, K
    Saito, H
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (02) : 205 - 208
  • [3] Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
    Kazuyuki Shimizu
    Eiichi Nagura
    Noriyuki Hirabayashi
    Atsushi Wakita
    Hideo Takeyama
    Hiroshi Sao
    Masakazu Nitta
    Kohei Kawashima
    Hidehiko Saito
    [J]. International Journal of Hematology, 2001, 74 : 205 - 208
  • [4] The rate of M-protein decrement predicts survival in multiple myeloma.
    Schaar, CG
    le Cessie, S
    te Marvelde, CM
    Wijermans, PW
    Kluin-Nelemans, HC
    [J]. BLOOD, 2000, 96 (11) : 156A - 156A
  • [5] MULTIPLE-MYELOMA WITHOUT M-PROTEIN
    AMIR, J
    [J]. JOURNAL OF THE ARKANSAS MEDICAL SOCIETY, 1978, 75 (03): : 118 - 118
  • [6] Changes in M-Protein at Multiple Myeloma Relapse
    Hobbs, J. A.
    Sharp, K.
    Harding, S. J.
    Drayson, M.
    Bradwell, A. R.
    Mead, G. P.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S27 - S27
  • [7] Atypical M-protein localization in protein electrophoresis in a patient with multiple myeloma
    Yildirim, Naciye Demirel
    Ayer, Mesut
    Hatipoglu, Esra
    Kucukkaya, Reyhan Diz
    Yenerel, Mustafa Nuri
    Nalcaci, Meliha
    [J]. TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2008, 25 (01): : 56 - 59
  • [8] LABORATORY SCREENING OF M-PROTEIN FOR EARLY DETECTION OF MULTIPLE-MYELOMA
    KITAMURA, M
    YAMAGUCHI, H
    MURAKAWA, K
    [J]. JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (08): : 730 - 731
  • [9] Establishing the Velocity of M-Protein Decline (VMD) Value in Response to Multiple Myeloma Therapy That Best Predicts M-Protein of Zero
    Haddad, Philip A.
    Ganey, Nowell
    [J]. BLOOD, 2020, 136
  • [10] Elevated normal immunoglobulins and stable M-protein levels in multiple myeloma patients on erythropoietin treatment.
    Gadassi, Noa
    Sagiv, Sari Prutchi
    Oster, Howard S.
    Newmann, Drorit
    Mittelman, Moshe
    [J]. BLOOD, 2007, 110 (11) : 260B - 260B
12345